Pharmavite Targets More Evidence To Support Challenged Omega-3 Claim
This article was originally published in The Rose Sheet
Pharmavite will not follow NAD’s recommendation to discontinue claim its NatureMade Omega 3 Xtra Blend fish oil supplement offers “nearly 4x better absorption” than standard fish oil, but plans another clinical study supporting the statement.
You may also be interested in...
NAD says that Westport Pharmaceuticals supported claims for Zephrex-D’s rate of relief and efficacy challenged by Acura Pharmaceuticals, manufacturer of Nexafed, another nonprescription PSE drug formulated to prevent extraction of the ingredient.
Pharmavite discontinues ads; NAD looks at supplement concussion claims; FDA warns product requires NDI; Spinal Touch Formulas are unapproved new drugs – FDA; Weight-loss products unapproved, misbranded; Oklahoma law restricting contraception knocked down; and Hammer Nutrition sued over “natural” claims
Washington State’s Toxic-Free Cosmetics Act would ban use of any and all PFAS, matching work California started in 2020 and finished with legislation enacted last year. It also would blacklist ortho-phthalates, formaldehyde, methylene glycol and any other chemical determined by the department to release formaldehyde, among other deemed hazardous substances.